Adherence to melanoma screening and surveillance skin check schedules tailored to personal risk
Population-wide skin cancer screening is not currently recommended in most countries. Instead, most clinical guidelines incorporate risk-based recommendations for skin checks, despite limited evidence around implementation and adherence to recommendations in practice. We aimed to determine adherence to personal risk-tailored melanoma skin check schedules and explore reasons influencing adherence. Patients (with/without a previous melanoma) attending tertiary dermatology clinics at the Melanoma Institute Australia, Sydney, Australia, were invited to complete a melanoma risk assessment questionnaire via iPad and provided with personal risk information alongside a risk-tailored skin check schedule. Data were collected from the risk tool, clinician-recorded data on schedule deviations, and appointment booking system. Post-consultation, we conducted semi-structured interviews with patients and clinic staff. We used a convergent segregated mixed methods approach for analysis. Interviews were audio recorded, transcribed and data were analysed thematically. Participant data were analysed from clinic records (n = 247) and interviews (n = 29 patients, 11 staff). Overall, there was 62% adherence to risk-tailored skin check schedules. In cases of non-adherence, skin checks tended to occur more frequently than recommended. Decisions to deviate were similarly influenced by patients (44%) and clinicians (56%). Themes driving non-adherence among patients included anxiety and wanting autonomy around decision-making, and among clinicians included concerns around specific lesions and risk estimate accuracy. There was moderate adherence to a clinical service program of personal risk-tailored skin check recommendations. Further adherence may be gained by incorporating strategies to identify and assist patients with high levels of anxiety and supporting clinicians to communicate risk-based recommendations with patients.
Authors
- Andrea L. Smith (ORCID: https://orcid.org/0000-0002-9194-4888)
- Anne Elizabeth Cust (ORCID: https://orcid.org/0000-0002-5331-6370)
- Linda K. Martin (ORCID: https://orcid.org/0000-0001-9519-7077)
- Amelia K. Smit (ORCID: https://orcid.org/0000-0001-5712-220X)
- Bruna Gallo
- Bela I. Laginha (ORCID: https://orcid.org/0000-0002-2856-1542)
- Pascale Guitera (ORCID: https://orcid.org/0000-0001-5713-3451)
- David Espinoza
- Ivy Tan
- Methmi M. Perera
Institutions
- The University of Sydney (AU)
- Royal Prince Alfred Hospital (AU)
- UNSW Sydney (AU)
- Melanoma Institute Australia (AU)
- National Health and Medical Research Council (AU)
- Cancer Council NSW (AU)
Publication Details
- Journal
- International Journal of Cancer
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1002/ijc.35146
- Citations
- 2
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- University of Warwick
- University of New South Wales
- University of Sydney
- Melanoma Institute Australia
- Medical Research Council
- National Health and Medical Research Council
- Melanoma Centre of Research Excellence